Quisel John D
Known title: Chief Executive OfficerCIK: 0001586788
Associated companies
Transaction History
| IRON | ▲ Buy | Option Exercise | 36,000 | $36K | 9/15/2026 | View on chart |
| IRON | ▲ Buy | Option Exercise | 33,000 | $446K | 8/17/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 8,400 | $656K | 8/17/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 12,712 | $1.0M | 8/17/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 11,888 | $949K | 8/17/2026 | View on chart |
| IRON | ▲ Buy | Option Exercise | 25,584 | $252K | 7/13/2026 | View on chart |
| IRON | ▲ Buy | Option Exercise | 7,416 | $100K | 7/13/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 9,704 | $721K | 7/13/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 16,896 | $1.3M | 7/13/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 6,400 | $487K | 7/13/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 22,927 | $1.6M | 6/18/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 9,522 | $673K | 6/18/2026 | View on chart |
| IRON | ▲ Buy | Option Exercise | 34,000 | $335K | 6/18/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 1,551 | $111K | 6/18/2026 | View on chart |
| IRON | ▼ Sell | Open Market | 13,264 | $834K | 2/17/2026 | View on chart |
| IRON | ▲ Buy | Grant | 55,200 | $0 | 2/10/2026 | View on chart |
| IRON | ▲ Buy | Option Exercise | 12,300 | $12K | 12/19/2025 | View on chart |
| IRON | ▲ Buy | Option Exercise | 40,000 | $394K | 12/11/2025 | View on chart |
| IRON | ▼ Sell | Open Market | 2,419 | $220K | 12/11/2025 | View on chart |
| IRON | ▼ Sell | Open Market | 16,356 | $1.5M | 12/11/2025 | View on chart |
| IRON | ▼ Sell | Open Market | 4,337 | $400K | 12/11/2025 | View on chart |
| IRON | ▼ Sell | Open Market | 16,888 | $1.6M | 12/11/2025 | View on chart |
| IRON | ▲ Buy | Option Exercise | 10,000 | $10K | 9/9/2025 | View on chart |
| IRON | ▲ Buy | Option Exercise | 34,800 | $343K | 7/9/2025 | View on chart |
| IRON | ▼ Sell | Open Market | 31,207 | $1.7M | 7/9/2025 | View on chart |
| IRON | ▼ Sell | Open Market | 3,593 | $202K | 7/9/2025 | View on chart |
| IRON | ▲ Buy | Option Exercise | 5,200 | $51K | 7/3/2025 | View on chart |
| IRON | ▼ Sell | Open Market | 5,200 | $286K | 7/3/2025 | View on chart |
| IRON | ▲ Buy | Option Exercise | 7,000 | $7K | 4/7/2025 | View on chart |
| IRON | ▼ Sell | Open Market | 5,574 | $304K | 2/18/2025 | View on chart |
| IRON | ▲ Buy | Grant | 78,337 | $0 | 2/10/2025 | View on chart |
| IRON | ▲ Buy | Option Exercise | 10,000 | $10K | 12/31/2024 | View on chart |
| IRON | ▲ Buy | Option Exercise | 13,012 | $128K | 12/30/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 11,112 | $687K | 12/30/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 1,900 | $119K | 12/30/2024 | View on chart |
| IRON | ▲ Buy | Option Exercise | 19,820 | $53K | 12/23/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 3,414 | $213K | 12/23/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 12,194 | $770K | 12/23/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 4,212 | $269K | 12/23/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 5,767 | $378K | 12/16/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 6,305 | $418K | 12/16/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 500 | $34K | 12/16/2024 | View on chart |
| IRON | ▲ Buy | Option Exercise | 12,791 | $13K | 12/16/2024 | View on chart |
| IRON | ▼ Sell | Open Market | 219 | $14K | 12/16/2024 | View on chart |
| IRON | ▲ Buy | Option Exercise | 3,000 | $3K | 7/8/2024 | View on chart |
| IRON | ▲ Buy | Grant | 66,365 | $0 | 1/10/2024 | View on chart |
| IRON | ▲ Buy | Option Exercise | 2,700 | $3K | 12/29/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Disc Medicine faces valuation scrutiny and whale activity
Recent commentary questions whether Disc Medicine's stock price fully reflects its market position relative to competitors. Additionally, the stock appeared on a list of healthcare names showing significant large-scale trading activity. The stock is currently trading near its 52-week low, which provides context for these recent market observations.
Disc Medicine faces valuation scrutiny and whale activity. Recent commentary questions whether Disc Medicine's stock price fully reflects its market position relative to competitors. Additionally, the stock appeared on a list of healthcare names showing significant large-scale trading activity. The stock is currently trading near its 52-week low, which provides context for these recent market observations.